In-silico ADME prediction and molecular docking study of novel benzimidazole-1,3,4-oxadiazole derivatives as CYP51 inhibitors for antimicrobial activity

In-silico ADME prediction and molecular docking study of novel benzimidazole-1,3,4-oxadiazole derivatives as CYP51 inhibitors for antimicrobial activity

A class of innovative benzimidazole-1,3,4-Oxadiazole derivatives is a significant heterocyclic molecule for therapeutic development. In heterocyclic chemistry, the novel 1,3,4-Oxadiazole nucleus has a wide range of uses, including antibacterial, treatment. Molecular docking is frequently employed in...

Full description

Bibliographic Details
Main Authors: Shivanand Kolageri, S Hemanth, Mahesh Parit
Format: Article
Language:English
Published: Creative Pharma Assent 2022-09-01
Series:Journal of Applied Pharmaceutical Research
Subjects:
1,3,4-oxadiazole
antimicrobial activity
in-silico adme prediction
molecular docking
Online Access:https://japtronline.com/index.php/joapr/article/view/275

Internet

https://japtronline.com/index.php/joapr/article/view/275

Similar Items